BAC Reports, an independent business R&D unit, was founded in 2001. From then onward, the company has been busy with presenting a broad set of research reports on diverse industry markets as well as offering other key analytical data and information. BAC’s foremost goal is to assist multinationals in improving business performance indicators and competing in the market segment they represent the best way possible. The company’s highly experienced and dedicated analyst team is striving to fill all the needs and expectations of their transnational clients.
The reports present comprehensive intelligence on the chemicals that have CAS registry numbers. The researches disclose a heap of valuable information on capacities, production and consumption trends, price changes, and foreign trade structural dynamics. Major raw materials, key patents, current and emerging CAS chemicals’ applications are detailed in the reports. Each product is described with regards to its molecular composition, storage and transportation, hazards assessment, toxicity level and sustainability, etc. Additionally, as the respective market’s future is predicted in the CAS chemicals reports.
Publications found:
98,007
Sort by:
Motavizumab (CAS 677010-34-3) Market Research Report 2024
US$ 2,200.00
BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
November 2024
50 pages
4-Ethyl-4,10-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (CAS 67656-30-8) Market Research Report 2024
US$ 2,200.00
BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
November 2024
50 pages
